1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Monoclonal Antibodies Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Monoclonal Antibodies Market, by Source
8.1.1. Humanized mAb
8.1.1.1. Market Revenue and Forecast
8.1.2. Human mAb
8.1.2.1. Market Revenue and Forecast
8.1.3. Murine mAb
8.1.3.1. Market Revenue and Forecast
8.1.4. Chimeric mAb
8.1.5.1. Market Revenue and Forecast
9.1. Ambulatory Surgical Center Market, by Indication
9.1.1. Cancer
9.1.1.1. Market Revenue and Forecast
9.1.2. Autoimmune Diseases
9.1.2.1. Market Revenue and Forecast
9.1.3. Inflammatory Diseases
9.1.3.1. Market Revenue and Forecast
9.1.4. Infectious Diseases
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. Monoclonal Antibodies Market, by Distribution Channel
10.1.1. Hospital Pharmacy
10.1.1.1. Market Revenue and Forecast
10.1.2. Online Pharmacy
10.1.2.1. Market Revenue and Forecast
10.1.3. Retail Pharmacy
10.1.3.1. Market Revenue and Forecast
11.1. Monoclonal Antibodies Market, by Production Methods
11.1.1. In Vivo
11.1.1.1. Market Revenue and Forecast
11.1.2. In Vitro
11.1.2.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Source
12.1.2. Market Revenue and Forecast, by Indication
12.1.3. Market Revenue and Forecast, by Distribution Channel
12.1.4. Market Revenue and Forecast, by Production Methods
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Source
12.1.5.2. Market Revenue and Forecast, by Indication
12.1.5.3. Market Revenue and Forecast, by Distribution Channel
12.1.5.4. Market Revenue and Forecast, by Production Methods
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Source
12.1.6.2. Market Revenue and Forecast, by Indication
12.1.6.3. Market Revenue and Forecast, by Distribution Channel
12.1.6.4. Market Revenue and Forecast, by Production Methods
12.2. Europe
12.2.1. Market Revenue and Forecast, by Source
12.2.2. Market Revenue and Forecast, by Indication
12.2.3. Market Revenue and Forecast, by Distribution Channel
12.2.4. Market Revenue and Forecast, by Production Methods
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Source
12.2.5.2. Market Revenue and Forecast, by Indication
12.2.5.3. Market Revenue and Forecast, by Distribution Channel
12.2.5.4. Market Revenue and Forecast, by Production Methods
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Source
12.2.6.2. Market Revenue and Forecast, by Indication
12.2.6.3. Market Revenue and Forecast, by Distribution Channel
12.2.6.4. Market Revenue and Forecast, by Production Methods
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Source
12.2.7.2. Market Revenue and Forecast, by Indication
12.2.7.3. Market Revenue and Forecast, by Distribution Channel
12.2.7.4. Market Revenue and Forecast, by Production Methods
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Source
12.2.8.2. Market Revenue and Forecast, by Indication
12.2.8.3. Market Revenue and Forecast, by Distribution Channel
12.2.8.4. Market Revenue and Forecast, by Production Methods
12.3. APAC
12.3.1. Market Revenue and Forecast, by Source
12.3.2. Market Revenue and Forecast, by Indication
12.3.3. Market Revenue and Forecast, by Distribution Channel
12.3.4. Market Revenue and Forecast, by Production Methods
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Source
12.3.5.2. Market Revenue and Forecast, by Indication
12.3.5.3. Market Revenue and Forecast, by Distribution Channel
12.3.5.4. Market Revenue and Forecast, by Production Methods
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Source
12.3.6.2. Market Revenue and Forecast, by Indication
12.3.6.3. Market Revenue and Forecast, by Distribution Channel
12.3.6.4. Market Revenue and Forecast, by Production Methods
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Source
12.3.7.2. Market Revenue and Forecast, by Indication
12.3.7.3. Market Revenue and Forecast, by Distribution Channel
12.3.7.4. Market Revenue and Forecast, by Production Methods
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Source
12.3.8.2. Market Revenue and Forecast, by Indication
12.3.8.3. Market Revenue and Forecast, by Distribution Channel
12.3.8.4. Market Revenue and Forecast, by Production Methods
12.4. MEA
12.4.1. Market Revenue and Forecast, by Source
12.4.2. Market Revenue and Forecast, by Indication
12.4.3. Market Revenue and Forecast, by Distribution Channel
12.4.4. Market Revenue and Forecast, by Production Methods
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Source
12.4.5.2. Market Revenue and Forecast, by Indication
12.4.5.3. Market Revenue and Forecast, by Distribution Channel
12.4.5.4. Market Revenue and Forecast, by Production Methods
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Source
12.4.6.2. Market Revenue and Forecast, by Indication
12.4.6.3. Market Revenue and Forecast, by Distribution Channel
12.4.6.4. Market Revenue and Forecast, by Production Methods
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Source
12.4.7.2. Market Revenue and Forecast, by Indication
12.4.7.3. Market Revenue and Forecast, by Distribution Channel
12.4.7.4. Market Revenue and Forecast, by Production Methods
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Source
12.4.8.2. Market Revenue and Forecast, by Indication
12.4.8.3. Market Revenue and Forecast, by Distribution Channel
12.4.8.4. Market Revenue and Forecast, by Production Methods
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Source Application
12.5.2. Market Revenue and Forecast, by Indication Application
12.5.3. Market Revenue and Forecast, by Distribution Channel Application
12.5.4. Market Revenue and Forecast, by Production Methods Application
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Source Application
12.5.5.2. Market Revenue and Forecast, by Indication Application
12.5.5.3. Market Revenue and Forecast, by Distribution Channel Application
12.5.5.4. Market Revenue and Forecast, by Production Methods Application
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Source Application
12.5.6.2. Market Revenue and Forecast, by Indication Application
12.5.6.3. Market Revenue and Forecast, by Distribution Channel Application
12.5.6.4. Market Revenue and Forecast, by Production Methods Application
13.1. Johnson & Johnson
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Merck
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. AbbVie
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Amgen
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GlaxoSmithKline plc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Norvatis AG
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Pfizer Inc.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Thermofischer Scientific
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Elililly and Company
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Bristol-Myers Squibb
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
